Arrestins as Regulators of Kinases and Phosphatases - Progress in Molecular Biology and Translational Science - page 141

91. Ahn S, Kim J, Hara MR, Ren XR, Lefkowitz RJ. Beta-arrestin-2 mediates anti-
apoptotic signaling through regulation of BAD phosphorylation. J Biol Chem .

2009;284:8855 - 8865.
92. Tournier C, Hess P, Yang DD, et al. Requirement of JNK for stress-induced activation
of the cytochrome c-mediated death pathway. Science . 2000;288:870 - 874.
93. Kuan CY, Whitmarsh AJ, Yang DD, et al. A critical role of neural-specific JNK3 for
ischemic apoptosis. Proc Natl Acad Sci USA . 2003;100:15184 - 15189.
94. Lin A, Defea KA. b -Arrestin-kinase scaffolds: turn them on or turn them off? Wiley
Interdiscip Rev Syst Biol Med . 2013;5:231 - 241.
95. Zhang TL, Fu JL, Geng Z, Yang JJ, Sun XJ. The neuroprotective effect of losartan
through inhibiting AT1/ASK1/MKK4/JNK3 pathway following cerebral I/R in rat
hippocampal CA1 region. CNS Neurosci Ther . 2012;18:981 - 987.
96. McAlees JW, Sanders VM. Hematopoietic protein tyrosine phosphatase mediates
beta2-adrenergic receptor-induced regulation of p38 mitogen-activated protein kinase
in B lymphocytes. Mol Cell Biol . 2009;29:675 - 686.
97. McLaughlin NJ, Banerjee A, Kelher MR, et al. Platelet-activating factor-induced
clathrin-mediated endocytosis requires beta-arrestin-1 recruitment and activation of
the p38 MAPK signalosome at the plasma membrane for actin bundle formation.
J Immunol . 2006;176:7039 - 7050.
98. Yang X, Zhou G, Ren T, et al. b -Arrestin prevents cell apoptosis through pro-
apoptotic ERK1/2 and p38 MAPKs and anti-apoptotic Akt pathways. Apoptosis .
2012;17:1019- 1026.
99. Wang Y, Tang Y, Teng L, Wu Y, Zhao X, Pei G. Association of beta-arrestin and
TRAF6 negatively regulates Toll-like receptor-interleukin 1 receptor signaling. Nat
Immunol . 2006;7:139 - 147.
100. Basher F, Fan H, Zingarelli B, et al. Beta-arrestin 2: a negative regulator of inflamma-
tory responses in polymorphonuclear leukocytes. Int J Clin Exp Med . 2008;1:32 - 41.
101. Finger EC, Lee NY, You HJ, Blobe GC. Endocytosis of the type III transforming
growth factor-beta (TGF-beta) receptor through the clathrin-independent/lipid raft
pathway regulates TGF-beta signaling and receptor down-regulation. J Biol Chem .
2008;283:34808 - 34818.
102. Mythreye K, Blobe GC. The type III TGF-beta receptor regulates epithelial and cancer
cell migration through beta-arrestin2-mediated activation of Cdc42. Proc Natl Acad Sci
USA . 2009;106:8221- 8226.
103. You HJ, How T, Blobe GC. The type III transforming growth factor-beta receptor
negatively regulates nuclear factor kappa B signaling through its interaction with
beta-arrestin2. Carcinogenesis . 2009;30:1281 - 1287.
104. Lin FT, Chen W, Shenoy S, Cong M, Exum ST, Lefkowitz RJ. Phosphorylation of
beta-arrestin2 regulates its function in internalization of beta(2)-adrenergic receptors.
Biochemistry . 2002;41:10692 - 10699.
105. Masri B, Salahpour A, Didriksen M, et al. Antagonism of dopamine D2 receptor/beta-
arrestin 2 interaction is a common property of clinically effective antipsychotics. Proc
Natl Acad Sci USA . 2008;105:13656 - 13661.
106. Hupfeld CJ, Resnik JL, Ugi S, Olefsky JM. Insulin-induced beta-arrestin1 Ser-412
phosphorylation is a mechanism for desensitization of ERK activation by Galphai-
coupled receptors. J Biol Chem . 2005;280:1016 - 1023.
107. Pitcher JA, Payne ES, Csortos C, DePaoli-Roach AA, Lefkowitz RJ. The G-protein-
coupled receptor phosphatase: a protein phosphatase type 2A with a distinct subcellular
distribution and substrate specificity. Proc Natl Acad Sci USA . 1995;92:8343 - 8347.
108. Krueger KM, Daaka Y, Pitcher JA, Lefkowitz RJ. The role of sequestration in
G protein-coupled receptor resensitization. Regulation of beta2-adrenergic receptor
dephosphorylation by vesicular acidification. J Biol Chem . 1997;272:5 - 8.